Our proven executive team brings deep, diverse cell therapy and oncology experience and is committed to developing safe, effective, and accessible NK cell therapies for cancer. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.
Fred Aslan, M.D.
President and Chief Executive OfficerView Bio »
EVP, Chief Legal & People OfficerView Bio »
Chief Financial OfficerView Bio »
Peter Flynn, Ph.D.
Chief Operating OfficerView Bio »
Thorsten Graef, M.D., Ph.D.
Chief Medical OfficerView Bio »
Chief Technical Operations OfficerView Bio »
Vice President, Regulatory Affairs & QualityView Bio »
Vice President, Finance and Corporate ControllerView Bio »
John Lim, Pharm.D.
Vice President, Clinical OperationsView Bio »
Heather Raymon, Ph.D.
SVP, Research & Early DevelopmentView Bio »